Payer+Provider's Health System Review
April 27, 2023
But experts say there’s little chance the Chinese chemical companies that sell ingredients to Mexican cartels will be prosecuted.
April 20, 2023
Drugmaker’s price is ‘still too expensive for pretty much everyone I’ve ever provided it to,’ epidemiologist says.
April 12, 2023
The designation comes as the animal sedative, known as ‘tranq,’ has proliferated on the streets, causing oozing wounds and dazed users.
April 7, 2023
‘This opens the door to the courts’ second-guessing any FDA approval — especially for drugs for controversial areas like gender-affirming care,’ expert says.
April 6, 2023
Critics say the measures recall the failed programs of the 1980s and ’90s that locked up users and low-level dealers without cutting off supply.
March 29, 2023
The FDA move came as a top Biden official called fentanyl overdose deaths ‘the single greatest challenge we face as a country.’
March 16, 2023
The FDA is poised to ease access to the overdose antidote, but experts predict limited impact unless the price comes down.
March 9, 2023
Almost half of women over 40 have dense breast tissue, which is tied to a higher risk of breast cancer — and also makes it harder to detect cancer.
March 5, 2023
Studies show methadone works. But draconian regulations make it hard to get even amid the drug crisis.
February 28, 2023
The drug, which is approved for use by veterinarians, is being mixed with illicit street drugs across the country.